NORTHRIDGE, Calif.--(BUSINESS WIRE)--Avita Medical Ltd. (ASX: AVH), the regenerative medicine company, announced today that a clinical study of 18 patients suffering from partial-thickness burns, some of which had failed to heal after treatment with other wound-healing methods (‘chronic wounds’), demonstrated successful wound-healing after being treated with ReCell® Spray-On Skin™ from Avita Medical. Results of the study (“Opportunities for ReCell® Autologous Cell Harvesting in Burns and Delayed Healing”) were presented last month at the 44th annual meeting of the British Burns Association by principal investigators Rajiv Sood, M.D., Professor of Surgery, Indiana University School of Medicine and Director, Richard M. Fairbanks Burn Center, Wishard Hospital, Indianapolis; and, Isabel Jones, M.D., Consulting Physician, Burns Unit, Chelsea and Westminster Hospital, London.
